Rapid Rise in Cases of Prostate Cancer Worldwide to Influence Growth of Prostate Cancer Therapeutics Market to a Great Extent: TMR
- Obesity and other related diseases are directly related to prostate cancer, thus increasing the incidence of prostate cancer, which fuels the need for prostate cancer therapeutics among a considerable populace
- The prostate cancer therapeutics market was valued at ~US$ 10 bn in 2019 and is expected to reach ~US$ 19.6 bn by 2027
ALBANY, N.Y, Nov. 24, 2020 /PRNewswire/ -- The prevalence of prostate cancer is magnifying across the world at a rapid rate. According to the estimates by the American Cancer Society, the U.S. may record 191,930 novel prostate cancer cases and nearly 33,330 deaths from prostate cancer. These alarming statistics highlight the rising incidences. Hence, this aspect may boost the growth rate of the prostate cancer therapeutics market to a great extent.
Prostate cancer starts when the prostate gland cells grow tremendously. This gland is found only in males. The prostate is below the bladder and in the front of the rectum. The rising geriatric population is also an indicator of growing prostate cancer cases as the majority of cases are detected in men over 65 years of age.
The thorough analysis conducted by the researchers at Transparency Market Research (TMR) prognosticates the global prostate cancer therapeutics market to expand at a healthy CAGR of ~8 percent from 2019 to 2027. The global prostate cancer therapeutics market was valued at ~US$ 10 bn in 2019 and is expected to reach ~US$ 19.6 bn by 2027.
The advent of promising therapies through extensive research and development activities, a considerable rise in the geriatric population, and incidences of urological disorders at an early age may invite expansive growth prospects for the prostate cancer therapeutics market during the assessment period of 2019-2027.
Prostate Cancer Therapeutics Market: Transparency Expert Diagnosis
The analysts at TMR expect the prostate cancer therapeutics market to display promising growth across the assessment period. The analysts advise the players in the prostate cancer therapeutics market to shift their production facilities to Asia Pacific as it can lead to decreased overhead expenses and eventually bring down the high prices of prostate cancer therapeutics.
Prostate Cancer Therapeutics Market: Major Findings
On the basis of distribution channel, the hospital pharmacies segment may garner extensive growth for the global prostate cancer therapeutics market
The hospital pharmacy segment is likely to account for half of the market share by recording a CAGR of ~9 percent across the assessment period of 2019-2027
The hormone segment therapy had a larger influence on the prostate cancer therapeutics market in terms of therapy in 2018 and may continue the same from 2019 to 2027
North America was the largest growth-contributing region in 2018
Asia Pacific is projected to incur maximum growth for the prostate cancer therapeutics market during the assessment period
Explore 206 pages of superlative research, current market scenario, and extensive geographical projections. Gain insights into the Prostate Cancer Therapeutics Market (Therapy: Hormone Therapy, Chemotherapy, Biologic Therapy, and Targeted Therapy; Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Sales, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 at https://www.transparencymarketresearch.com/report-toc/6562
Prostate Cancer Therapeutics Market: Growth Propellers
Emerging diagnostic techniques have a great effect on the growth of the prostate cancer therapeutics market and may influence it to a certain extent.
Advances in prostate cancer therapeutics such as abiraterone acetate, enzalutamide, cabazitaxel, radium-233, and others may bring tremendous growth opportunities
Cost-effective treatment options for certain therapies across various countries may further boost the growth of the prostate cancer therapeutics market
Prostate Cancer Therapeutics Market: Growth Restraints
Some therapies have high costs and this may prove to be a prominent restraint for the adoption of these therapies. Less awareness about these therapies in developing countries may further dampen the growth of the prostate cancer therapeutics market. Chemotherapy is also not a feasible option in the later stages of prostate cancer. Hence, all these aspects may restrain the prostate cancer therapeutics market to a certain extent.
Global Prostate Cancer Therapeutics Market: Segmentation
By Distribution Channel
Middle East & Africa
Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:
Breast Cancer Therapeutics Market: Transparency Market Research forecasts that the global breast cancer therapeutics market is expected to be worth US$16.21 bn by 2023 as compared to US$7.17 bn in 2014, surging at a CAGR of 8.4% between 2015 and 2023. The drastically changing reproductive patterns are also responsible for soaring revenue earnings of the breast cancer therapeutics market.
Tumor Ablation Market: The market is anticipated to exhibit an exponential growth in the years to come. Rapid adoption of new type of treatment to fight cancer with better efficiency of tumor ablation against traditional therapies is favoring the tumor ablation market. Apart from this, increasing public awareness programs in order to detect cancer at a very first step along with funds provided by government of various countries for cancer research, particularly in developed countries is stoking the tumor ablation market.
Cancer Immunotherapy Market: The global cancer immunotherapy market is prognosticated to encounter a high rate of development over the coming years, inferable from the rise in number of people suffering from different types of cancers. In 2015, the global cancer immunotherapy market was esteemed at US$37.50 bn. its revenue is anticipated to progress at an extremely solid CAGR of 14.6% inside a conjecture period from 2016 to 2024, the global cancer immunotherapy market is required to achieve US$124.88 bn before the finish of 2024.
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."